Druglikeness 

Druglikeness is a qualitative concept used in drug design for how "druglike" a substance is. It is estimated from the molecular structure before the substance is even synthesized and tested. A druglike molecule has properties like this:

Based on this information, druglikeness indexes can be constructed. A good druglikeness index gives the green light to known, effective drugs but rejects most other known chemicals. Ideally, using a druglikeness index leads to rejecting nonviable lead compounds before they are even synthesized. One of the traditional rules of thumb is Lipinski's Rule of Five.

Also, other factors such as substructures with known toxic, mutagenic or teratogenic effects affect the usefulness of a designed molecule. In fact, several poisons have a good druglikeness. Natural toxins are used in pharmacological research to find out their mechanism of action, and if it could be exploited for beneficial purposes.

Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.